Perrigo | PRGO - Net Income


Perrigo reported $74.5M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
AbbVie USD 3.61B 2.92B Jun/2026
Abbott USD 928M 149M Jun/2026
Bayer EUR 2.76B 6.52B Mar/2026
Bristol-Myers Squibb USD 3.32B 640M Jun/2026
Coherus Biosciences USD -37.64M 2.11M Dec/2025
Corcept Therapeutics USD 42.14M 73.9M Jun/2026
Dr.Reddys Laboratories INR 4.44B 2.23B Jun/2026
Eli Lilly USD 7.1B 301M Jun/2026
J&J USD 5.53B 299M Jun/2026
Merck USD -1.34B 2.9B Jun/2026
Nestle CHF 3.47B 496M Jun/2026
Pacira USD 4.65M 1.74M Jun/2026
Perrigo USD 74.5M 473.1M Jun/2026
Pfizer USD -248M 2.94B Jun/2026
Phibro Animal Health USD 27.46M 932K Dec/2025
Prestige Brands USD 46.7M 22.44M Dec/2025
Reckitt Benckiser GBP 284M 287M Dec/2024
Sanofi EUR 343M 1.27B Jun/2026
Supernus Pharmaceuticals USD -58.37M 56.08M Jun/2026
Teva Pharmaceutical Industries USD -576M 945M Jun/2026
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026
Zoetis USD 601M 2M Mar/2026